Tabrecta 200 mg Tablet contains capmatinib, a prescription targeted cancer medicine. Use for certain adults with non-small cell lung cancer (NSCLC) whose tumors have specific MET alterations, as determined by appropriate testing.

Capmatinib 200 mg is a selective MET inhibitor that works by blocking. MET signaling involved in cancer cell growth and spread. Tabrecta is taken orally according to the dosage and treatment schedule prescribed by an oncologist.

The Tabrecta 200 mg price, Tabrecta price in India. Capmatinib 200 mg price may vary depending on the supplier, packaging, and availability. Treatment should be continued only as directed by the treating healthcare professional.

Product: Tabrecta 200 mg Tablet
Active Ingredient: Capmatinib
Strength: 200 mg
Form: Tablet
Drug Class: MET Inhibitor
Category: Prescription Targeted Cancer Therapy